Suppr超能文献

在新冠疫情期间虚拟启动一项产前阿片类药物暴露研究的经验教训

Lessons Learned in Virtual Launch of an Antenatal Opioid Exposure Study During the COVID-19 Pandemic.

作者信息

Newman Jamie E, Dhawan Megan, Clarke Leslie, Owen Sharon, Beiersdorfer Traci, Parlberg Lindsay M, Merhar Stephanie L, DeMauro Sara B, Lorch Scott A, Wilson-Costello Deanne, Ambalavanan Namasivayam, Peralta-Carcelen Myriam, Poindexter Brenda, Davis Jonathan M, Mack Nicole, Limperopoulos Catherine, Bann Carla M

出版信息

Nurs Res. 2025;74(3):218-224. doi: 10.1097/NNR.0000000000000807. Epub 2025 Jan 24.

Abstract

BACKGROUND

The COVID-19 pandemic prompted researchers to develop new ways to design and launch studies and recruit and retain participants. Pregnant women and infants are considered vulnerable populations in research, and families affected by substance use are particularly difficult to recruit and retain. Recruitment for studies involving medical technologies such as MRI can also be difficult due to misconceptions and fear of the technologies.

OBJECTIVES

This article aims to describe "lessons learned" during the launch of the Outcomes of Babies with Opioid Exposure (OBOE) study, including successes and challenges when working with high-risk infants and families and the importance of engaging participants through recruitment materials and retention efforts.

METHODS

The OBOE study is a multisite prospective longitudinal cohort study comparing infants with antenatal opioid exposure to unexposed controls from birth to 2 years of age. Chi-square tests were used to examine refusal reasons among caregivers of eligible infants by exposure group and differences in 6-month retention among subgroups based on social determinants of health.

RESULTS

Four factors were essential in establishing the consortium, implementing the study, and retaining participants: (a) creating venues for collaboration, (b) pivoting from in-person to virtual training, (c) anticipating potential enrollment barriers and addressing them directly, and (d) engaging participants through recruitment materials and retention efforts. With these factors in place, only 5% of caregivers of eligible opioid-exposed infants and 8% of control infants declined to participate in the study because of MRIs. Of 310 enrolled infants, 234 infants had attended the 6-month visit. Subgroups of enrolled infants were similar in retention at 6 months.

DISCUSSION

Reporting our successes and challenges in setting up a nationwide consortium during the pandemic may help other consortia that need to be set up virtually. We anticipated that the serial MRIs would be a barrier to participation; however, few indicated they refused to participate because of MRIs, suggesting that our efforts to address this potential barrier to enrollment were successful.

摘要

背景

新冠疫情促使研究人员开发设计和开展研究以及招募和留住参与者的新方法。孕妇和婴儿在研究中被视为弱势群体,而受物质使用影响的家庭尤其难以招募和留住。由于对诸如磁共振成像(MRI)等医疗技术存在误解和恐惧,涉及此类技术的研究招募工作也可能存在困难。

目的

本文旨在描述阿片类药物暴露婴儿结局(OBOE)研究启动过程中的“经验教训”,包括与高危婴儿及其家庭合作时的成功与挑战,以及通过招募材料和留存工作吸引参与者的重要性。

方法

OBOE研究是一项多中心前瞻性纵向队列研究,比较产前暴露于阿片类药物的婴儿与未暴露的对照组婴儿从出生到2岁的情况。采用卡方检验来检查符合条件婴儿的照料者按暴露组划分的拒绝原因,以及基于健康的社会决定因素的亚组在6个月留存率方面的差异。

结果

有四个因素对于建立联盟、开展研究和留住参与者至关重要:(a)创建合作场所;(b)从面对面培训转向虚拟培训;(c)预测潜在的入组障碍并直接加以解决;(d)通过招募材料和留存工作吸引参与者。有了这些因素,符合条件的阿片类药物暴露婴儿的照料者中只有5%、对照组婴儿的照料者中只有8%因磁共振成像检查而拒绝参与研究。在310名入组婴儿中,有234名婴儿参加了6个月的随访。入组婴儿的亚组在6个月时的留存情况相似。

讨论

报告我们在疫情期间建立全国性联盟过程中的成功与挑战,可能会对其他需要虚拟建立的联盟有所帮助。我们预计系列磁共振成像检查会成为参与的障碍;然而,很少有人表示他们因磁共振成像检查而拒绝参与,这表明我们为解决这一潜在入组障碍所做的努力是成功的。

相似文献

1
Lessons Learned in Virtual Launch of an Antenatal Opioid Exposure Study During the COVID-19 Pandemic.
Nurs Res. 2025;74(3):218-224. doi: 10.1097/NNR.0000000000000807. Epub 2025 Jan 24.
3
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Behavioral interventions to reduce risk for sexual transmission of HIV among men who have sex with men.
Cochrane Database Syst Rev. 2008 Jul 16(3):CD001230. doi: 10.1002/14651858.CD001230.pub2.
6
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
7
Service Interruption in HIV Care Amid COVID-19 Pandemic in Myanmar: Results From Analysis of Routine Program Data 2018-2022.
J Int Assoc Provid AIDS Care. 2024 Jan-Dec;23:23259582241299466. doi: 10.1177/23259582241299466.
8
Physical interventions to interrupt or reduce the spread of respiratory viruses.
Cochrane Database Syst Rev. 2023 Jan 30;1(1):CD006207. doi: 10.1002/14651858.CD006207.pub6.

本文引用的文献

1
Comparing maternal substance use and perinatal outcomes before and during the COVID-19 pandemic.
J Perinatol. 2023 May;43(5):664-669. doi: 10.1038/s41372-023-01613-8. Epub 2023 Feb 6.
2
Outcomes of Babies with Opioid Exposure (OBOE): protocol of a prospective longitudinal cohort study.
Pediatr Res. 2023 May;93(6):1772-1779. doi: 10.1038/s41390-022-02279-2. Epub 2022 Aug 30.
3
Impact of Coronavirus Disease-2019 on Hospital Care for Neonatal Opioid Withdrawal Syndrome.
J Pediatr. 2022 Jun;245:47-55. doi: 10.1016/j.jpeds.2022.02.001. Epub 2022 Feb 5.
4
Neonatal Abstinence Syndrome and Maternal Opioid-Related Diagnoses in the US, 2010-2017.
JAMA. 2021 Jan 12;325(2):146-155. doi: 10.1001/jama.2020.24991.
5
Opioid Use Disorder Documented at Delivery Hospitalization - United States, 1999-2014.
MMWR Morb Mortal Wkly Rep. 2018 Aug 10;67(31):845-849. doi: 10.15585/mmwr.mm6731a1.
6
A Public Health Response to Opioid Use in Pregnancy.
Pediatrics. 2017 Mar;139(3). doi: 10.1542/peds.2016-4070. Epub 2017 Feb 20.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验